NeuroDerm Ltd. Ordinary Shares
NDRM
NDRM was delisted on the 17th of October, 2017.
50 hedge funds and large institutions have $151M invested in NeuroDerm Ltd. Ordinary Shares in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 10 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
36% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 14
12% more capital invested
Capital invested by funds: $134M → $151M (+$16.8M)
0% more funds holding
Funds holding: 50 → 50 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
59% less call options, than puts
Call options by funds: $281K | Put options by funds: $680K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$6.74M |
| 2 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$2.43M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$1.77M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.55M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$680K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$6.05M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$3.25M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
-$3.11M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$2.04M |
| 5 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$1.53M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RCM
51
RA Capital Management
Boston,
Massachusetts
| – | -$2.04M | -144,671 | Closed |
|
52
Goldman Sachs
New York
| – | -$1.47M | -104,334 | Closed |
|
|
NC
53
Nexthera Capital
New York
| – | -$988K | -70,000 | Closed |
|
54
HighTower Advisors
Chicago,
Illinois
| – | -$171K | -12,150 | Closed |
|
55
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| – | -$132K | -9,200 | Closed |
|
56
Wells Fargo
San Francisco,
California
| – | -$78K | -5,500 | Closed |
|
|
EDRE
57
Edmond de Rothschild (Europe)
Luxembourg
| – | -$23K | -1,600 | Closed |
|
|
EDRH
58
Edmond de Rothschild Holding
Chambesy,
Switzerland
| – | -$23K | -1,600 | Closed |
|
|
TI
59
Turner Investments
Berwyn,
Pennsylvania
| – | -$14K | -1,000 | Closed |
|
|
TRCT
60
Tower Research Capital (TRC)
New York
| – | -$5K | -341 | Closed |
|
NDRM Hedge Fund Activity: Q2 2016 in Review
50 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q2 2016, worth a combined $151M — up 12% from $134M a quarter earlier.
Fund positioning in NDRM was balanced in Q2 2016: 10 funds opened new positions, 10 closed out, 19 added to existing stakes and 14 trimmed.
The largest buyer was Menora Mivtachim Holdings, adding an estimated $6.74M. The largest seller was Redmile Group, cutting an estimated $6.05M.
- 50 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $151M of NeuroDerm Ltd. Ordinary Shares stock for Q2 2016, up 12% quarter-over-quarter.
- 10 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q2 2016 and 10 closed out, a net change of 0 holders.
- The largest NeuroDerm Ltd. Ordinary Shares buyer in Q2 2016 was Menora Mivtachim Holdings, an estimated $6.74M added.
- The largest NeuroDerm Ltd. Ordinary Shares seller in Q2 2016 was Redmile Group, an estimated $6.05M sold.
Based on aggregated 13F filings for Q2 2016.